Clinical trial
Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
NCT03516656 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
- Lead sponsor
- University of Utah
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 23, 2018
- Completion date
- August 24, 2021
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
deep vein thrombosis, pulmonary embolism, venous thromboembolism